Form 4: Elanco Animal Health CEO Jeffrey Simmons Reports Acquisition of Deferred Stock Units

Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units on May 31, 2024.

Summary

• On May 31, 2024, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired deferred stock units.
• The transaction involved the acquisition of 156.6312 deferred stock units, each representing the right to receive one share of Elanco's common stock or the cash equivalent.
• These deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.
• Following the reported transaction, Simmons directly owns 1,960.6848 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation transaction, which is generally viewed neutrally to positively as it aligns management interests with shareholders. The sentiment is slightly positive due to the incentive structure.

Positives

• The acquisition of deferred stock units by the CEO aligns his interests with those of the shareholders.
• The deferred stock units incentivize long-term commitment and performance from the CEO.

Future Outlook

The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation through stock and deferred stock units is a common practice in the animal health industry to align management's interests with shareholder value and incentivize long-term performance. This filing reflects standard executive compensation practices.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded animal health companies such as Zoetis and IDEXX Laboratories.
• These companies often use a mix of stock options, restricted stock units, and performance-based equity awards to incentivize their executives.
• The specific terms and conditions of these awards, such as vesting schedules and performance metrics, can vary widely depending on the company's size, growth stage, and strategic priorities.

Stakeholder Impact

• The acquisition of deferred stock units by the CEO can positively impact shareholders by aligning management's interests with long-term company performance.

Key Dates